J. C. Hodges

发表

Bicyclo 6.1.0 nonyne Phoshoramidites for Metal-Free Conjugation of Oligonucleotides

B. Gibson, J. Verkade, N. Barta, 2013 .

Combinatorial synthesis of dihydropyridone libraries and their derivatives

J. C. Hodges, M. Creswell, G. Bolton, 1998 .

Chapter 17. Ras Oncogene Directed Approaches in Cancer Chemotherapy

J. Sebolt-Leopold, J. C. Hodges, G. Bolton, 1994 .

Oligonucleotide Tagging for Copper-Free Click Conjugation

A. Rowan, F. V. van Delft, Sudip Malik, 2013, Molecules.

Chapter 6. Antihypertensive Agents

H. W. Hamilton, J. C. Hodges, David G. Taylor, 1989 .

Subclasses of angiotensin II binding sites and their functional significance.

R. Panek, G. Lu, T. Major, 1990, Molecular pharmacology.

Solid-supported syntheses of 3-thio-1,2,4-triazoles

A. Calvet, J. C. Hodges, M. Wilson, 1997, Molecular Diversity.

Rapid optimization of an ICE inhibitor synthesis using multiple reaction conditions in a parallel array.

J. Warmus, R. Kennedy, J. C. Hodges, 1998, Bioorganic & medicinal chemistry letters.

Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.

I. Sen, J. C. Hodges, A. Husain, 1991, Endocrinology.

Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.

C. J. Blankley, J. C. Hodges, J. Quin, 1991, Journal of medicinal chemistry.

Overview Cardiovascular & Renal: Angiotensin antagonists: agents that interact with the AT2 receptor and their potential therapeutic utilities

J. C. Hodges, 1994 .

Characterization of the Antiviral Activity of Highly Substituted Pyrroles: A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor

J. Warmus, J. C. Hodges, T. Antonucci, 1995 .

Synthesis of a taxane triene

Stephen E. Johnson, J. C. Hodges, A. Kende, 1986 .

Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.

A. Doherty, J. Sebolt-Leopold, J. C. Hodges, 1997, Journal of medicinal chemistry.

Solid-Supported tert-Alkoxycarbonylation Reagents for Anchoring of Amines during Solid Phase Organic Synthesis.

J. C. Hodges, Andrés S. Hernández, 1997, The Journal of organic chemistry.

Reactions of lithiooxazole

J. C. Hodges, C. Connolly, W. Patt, 1991 .

Polymer-Supported Quenching Reagents for Parallel Purification

J. C. Hodges, John C. Hodges, R. John Booth and, 1997 .

Synthesis of Amino 1,3-Diols. Ring Opening of N-Acyl Activated Lactams with Carbon Nucleophiles

J. M. Hamby, M. Reily, M. Taylor, 1993 .

Solid phase synthesis of fused bicyclic amino acid derivatives via intramolecular Pauson-Khand cyclization: Versatile scaffolds for combinatorial chemistry

J. Rubin, J. C. Hodges, G. Bolton, 1997 .

a-Amino Ketones from Amino Acids as Precursors for the Knorr Pyrrole Synthesis

J. M. Hamby, J. C. Hodges, 1993 .

4,5,6,7‐Tetrahydro‐1H‐imidazo[4,5‐c]pyridine‐6‐carboxylic acids (spinacines)

C. J. Blankley, J. C. Hodges, S. Klutchko, 1991 .

Solid-Supported Reagent Strategies for Rapid Purification of Combinatorial Synthesis Products

J. C. Hodges, John C. Hodges, R. John Booth and, 1999 .

New inhibitors of human renin that contain novel replacements at the P2 site.

A. Doherty, M. Taylor, J. C. Hodges, 1991, Journal of medicinal chemistry.

Synthesis of Amino 1,3-Diols, e.g. (V) - (VIII). Ring Opening of N- Acyl Activated Lactams, e.g. (I), with Carbon Nucleophiles, e.g. (II), (XI).

J. M. Hamby, M. Reily, M. Taylor, 1993 .

Stereospecific Synthesis of S,S-Statine and its Congeners

J. C. Hodges, S. Klutchko, P. O'brien, 1989 .

Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.

C. Humblet, E. Lunney, J. C. Hodges, 1991, Journal of medicinal chemistry.

A facile rearrangement of N-alkyl, N-(0 or p-nitrophenylsulfonamide)-α-amino esters

J. Rubin, J. C. Hodges, W. William, 1999 .

Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.

J. C. Hodges, W. Remers, W. T. Bradner, 1981, Journal of medicinal chemistry.

Polymer‐Supported Quenching Reagents for Parallel Purification.

J. C. Hodges, R. Booth, 1997 .

Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.

J. Cooper, E. Lunney, W. Lowther, 1993, Journal of medicinal chemistry.

Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists.

J. M. Hamby, R. Panek, J. C. Hodges, 1995, Journal of medicinal chemistry.

Phenacyl-directed alkylation of imidazoles: a new regiospecific synthesis of 3-substituted L-histidines

J. C. Hodges, Cleo J. Chivikas, 1987 .

8-Amino-6-(arylsulphonyl)-5-nitroquinolines: Novel nonpeptide neuropeptide Y1 receptor antagonists

T. Heffner, D. Downing, J. C. Hodges, 1996 .

8‐Amino‐6‐(arylsulfonyl)‐5‐nitroquinolines: Novel Nonpeptide Neuropeptide Y1 Receptor Antagonists.

T. Heffner, D. Downing, J. C. Hodges, 1996 .

Medicinal Chemistry of AT2 Receptors

J. C. Hodges, J. Edmunds, 1994 .

Regioselective C-3 Alkylations of Oxindole Dianion

J. C. Hodges, A. Kende, 1982 .

Solid‐Supported Reagent Strategies for Rapid Purification of Combinatorial Synthesis Products

J. C. Hodges, R. Booth, 1999 .

Tetrahydroisoquinoline derivatives with AT2-specific angiotensin II reception binding inhibitory activity

J. C. Hodges, S. Klutchko, J. Hamby, 1994 .

Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.

J. Keiser, J. C. Hodges, D. Taylor, 1992, The Journal of pharmacology and experimental therapeutics.

Weed Control Potential and Crop Safety of Selected Herbicides in Field-grown Cannas

J. C. Hodges, R. Wallace, 2007 .

Regiospecific Synthesis of 3-Substituted L-Histidines

J. C. Hodges, 1987 .

ANGIOTENSIN II RECEPTOR BINDING INHIBITORS

C. J. Blankley, J. C. Hodges, J. Hamby, 1992 .

TEMPO‐methyl‐polystyrene resin

C. Lindsley, J. C. Hodges, 2005 .

Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.

R. Panek, G. Lu, T. Major, 1995, The Journal of pharmacology and experimental therapeutics.

Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.

R. Panek, J. Keiser, J. C. Hodges, 1995, The Journal of pharmacology and experimental therapeutics.